<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260425069152N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-28</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of Anterior Cruciate Ligament Reconstruction(ACL) Using Isolated Techniques Versus Combined Reconstruction with the Anterior Oblique Ligament (AOL) on Rotational Stability and Clinica</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Evaluation of Anterior Cruciate Ligament Reconstruction(ACL) Using Isolated Techniques Versus Combined Reconstruction with the Anterior Oblique Ligament (AOL) on Rotational Stability and Clinical–Functional Outcomes: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/93266</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization sequence will be generated using the Sealed Envelope website. Twenty blocks of three and six blocks of six will be generated. The treatment allocation for each participant will then be placed in sequentially numbered, sealed envelopes by an individual who is not involved in the research team, and the envelopes will be provided to the researchers, Blinding description: This study will be conducted as a double-blind trial. Participants and outcome assessors will be blinded to participants’ group allocation. The randomization sequence will be generated by an individual outside the research team, and treatment allocation will be placed in sequentially numbered, sealed envelopes. Therefore, neither the investigator responsible for outcome assessment nor the participants will be aware of the assigned treatment group.

Before surgery, all participants will be informed about the study protocol, and written informed consent will be obtained from all participants. Participants will then be randomly allocated to one of the two surgical groups; however, they will not be informed whether anterolateral ligament (AOL) reconstruction will be performed.

The group allocation will be concealed in sequentially numbered, opaque, sealed envelopes. The relevant envelope will be opened by the surgeon immediately before surgery, without the participant being present or informed of the allocation. Information regarding the type of surgical intervention will be documented in the operative report and other surgical records in a manner that prevents access to this information by the participant.

After surgery, both groups will follow the same rehabilitation protocol and identical follow-up schedule, and participants will remain unaware of their group allocation throughout the follow-up period. Outcome assessments will be performed by an independent assessor who is blinded to the participants’ group allocation. Due to the nature of the surgical intervention, the surgeon and members of the treatment team directly involved in the surgical procedure cannot be blinded and will not participate in outcome assessment or statistical analysis. Statistical analysis will be performed using coded treatment groups, with the statistician blinded to the type of intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Complete Tear of the Anterior Cruciate Ligament (ACL) of the Knee.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients aged 16–45 years with a complete anterior cruciate ligament (ACL) tear confirmed by MRI and positive rotational instability on clinical examination who will undergo anterior cruciate ligament (ACL) reconstruction combined with anterior oblique ligament reconstruction. Intervention 2: Control group: Includes patients aged 16–45 years with a complete ACL tear confirmed by MRI and positive rotational instability on clinical examination who will undergo isolated anterior cruciate ligament reconstruction (ACLR).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Due to confidentiality considerations and the protection of participants’ information, there is no plan to share individual participant data.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sanaz Zabihi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ghaem Hospital, Ahmadabad Street, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>١٣٩۴۴ ٩١٣٨٨</zip>
        <telephone>+98 51 3841 7453</telephone>
        <email>yaqubkeykha2993@gmial.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Zarei Dezkooh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ghaem Hospital, Ahmadabad Street, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>١٣٩۴۴ ٩١٣٨٨</zip>
        <telephone>+98 51 3841 7453</telephone>
        <email>mohammadzarei22@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Complete ACL tear confirmed by MRI
Positive rotational instability on physical examination
Willingness to undergo surgery and participate in 6 months of follow-up</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Multiligament injury
Previous ACL reconstruction
Severe osteoarthritis
History of major knee surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S83.51</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sprain of anterior cruciate ligament of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients aged 16–45 years with a complete anterior cruciate ligament (ACL) tear confirmed by MRI and positive rotational instability on clinical examination who will undergo anterior cruciate ligament (ACL) reconstruction combined with anterior oblique ligament reconstruction.</i_keyword>
      <i_keyword>Control group: Includes patients aged 16–45 years with a complete ACL tear confirmed by MRI and positive rotational instability on clinical examination who will undergo isolated anterior cruciate ligament reconstruction (ACLR).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Rotational Instability. Timepoint: Preoperatively, 3 Months, and 6 Months Postoperatively. Method of measurement: pivot-Shift Test and slocum test.</prim_outcome>
      <prim_outcome>Anterior Knee Laxity. Timepoint: Preoperatively, 3 Months, and 6 Months Postoperatively. Method of measurement: anterior drawer test.</prim_outcome>
      <prim_outcome>Functional Outcomes. Timepoint: Preoperatively, 3 Months, and 6 Months Postoperatively. Method of measurement: Knee Society Score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-16</approval_date>
        <contact_name>Biomedical Research Ethics Committee of Imam Reza (AS) Hospital</contact_name>
        <contact_address>Imam Reza Hospital, Ibn Sina Street, Adjacent to Imam Reza Square, Mashhad, Iran Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
